PTAB challenges

Proceedings overview

There is one AIA trial proceeding on file for US Patent 9055868: IPR2025-01249, which resulted in a discretionary denial. This outcome means no claims were invalidated or sustained through this proceeding. The patent's claims remain untested by this particular IPR challenge, suggesting a defendant would face a patent whose claims have not been substantively challenged and affirmed or rejected by the PTAB.

IPR2025-01249 — SAMSUNG ELECTRONICS CO., LTD. et al. v. Mohammed N. ISLAM

• Type: Inter Partes Review
• Filed: 2025-08-05
• Status: Discretionary Denial. This means the PTAB declined to institute the IPR based on discretionary factors, rather than on the merits of the patentability challenge.
• Judge panel: Not publicly available from the provided patent text or standard search for institution decisions.
• Petition grounds: The patent text indicates the petitioner is SAMSUNG ELECTRONICS CO., LTD. et al. and the inventor is Mohammed N. ISLAM, but the specific claims challenged, prior art asserted, and statutory bases (§ 102 / § 103 / § 112) are not detailed in the provided data.
• Institution decision: Denied (Discretionary Denial). The PTAB declined to institute the IPR. The specific reasoning for the discretionary denial would be found in the institution decision, but it is not available in the provided patent text.
• Final Written Decision (if issued): Not issued, as institution was denied.
• Settlement / termination: No settlement or termination explicitly stated; the proceeding concluded with a discretionary denial of institution.
• Appeal: No Federal Circuit appeal related to a Final Written Decision, as no such decision was rendered.
• Defensive value: This IPR did not result in any claims being invalidated, nor did it substantively test the patentability of the claims on the merits. A defendant still faces a patent whose claims have not been judicially reviewed by the PTAB for patentability over the cited prior art. The fact that institution was denied on discretionary grounds (and not on the merits) means the underlying patentability arguments were not fully explored.

Strategic summary

Currently, none of the claims of US Patent 9055868 have been canceled or sustained through a final written decision from the provided PTAB proceeding. The single identified IPR (IPR2025-01249) was discretionarily denied institution, meaning the PTAB did not reach the merits of the patentability challenge. Therefore, all claims of US9055868 can be considered UNTESTED in the context of AIA trial proceedings to date.

Regarding the estoppel landscape, since IPR2025-01249 was denied institution on discretionary grounds rather than on the merits of patentability, it is unlikely to trigger the full estoppel provisions of 35 U.S.C. § 315(e)(2) for the petitioner. This means that, theoretically, the same petitioner (and their privies) might not be barred from raising the same grounds in a future proceeding if discretionary factors change, although the PTAB has discretion to consider prior denials. For a different defendant currently being asserted against, all prior-art grounds would generally still be available for a new IPR petition, as the merits were not decided in IPR2025-01249.

The signal from this single proceeding is limited. The discretionary denial indicates a procedural hurdle rather than a substantive victory or loss on patentability. The petitioner was "SAMSUNG ELECTRONICS CO., LTD. et al.", suggesting a large entity sought to challenge the patent. The presence of Unified Patents data in the Google Patents record for this IPR (IPR2025-01249) as "Not Instituted - Procedural" and indicating "Petitioner: Unified Patents PTAB Data" suggests that Unified Patents may have been involved in tracking or potentially initiating this IPR, though the primary petitioner is listed as SAMSUNG.

Recommended next steps

• Since IPR2025-01249 resulted in a discretionary denial of institution and not a Final Written Decision on the merits, there are no claims invalidated or sustained by this proceeding to explicitly link to. The procedural status means the patent claims have not been substantively challenged and affirmed or rejected by the PTAB.
• No active proceedings are currently pending that would require monitoring for trial-stage milestones.
• Given that there has been only one IPR filing which was discretionarily denied, and the patent is involved in multiple district court litigations (as indicated by the Google Patents record), a defendant should carefully consider the grounds for the discretionary denial of IPR2025-01249. If the patent is being asserted, the absence of successful PTAB challenges means that any new IPR petition would be a fresh attempt at invalidation, and the arguments presented in the denied petition should be reviewed to understand potential PTAB concerns or strategies to avoid.## Proceedings overview
  There is one AIA trial proceeding on file for US Patent 9055868: IPR2025-01249, which resulted in a discretionary denial. This outcome means no claims were invalidated or sustained through this proceeding. The patent's claims remain untested by this particular IPR challenge, suggesting a defendant would face a patent whose claims have not been substantively challenged and affirmed or rejected by the PTAB.

For each proceeding (most-impactful first — claims-invalidated ones go to the top):

IPR2025-01249 — SAMSUNG ELECTRONICS CO., LTD. et al. v. Omni Medsci Inc

• Type: Inter Partes Review
• Filed: 2025-08-05
• Status: Discretionary Denial. This means the PTAB declined to institute the IPR based on discretionary factors, rather than on the merits of the patentability challenge.
• Judge panel: Information regarding the specific judge panel for IPR2025-01249 is not publicly available in the provided text or readily found through general searches for "IPR2025-01249 judge panel". It's possible that with Director Squires taking personal control of all institution determinations since October 2025, many routine decisions are issued as summary notices without detailed explanations of reasoning or specific panel judge listings.
• Petition grounds: The specific claims challenged, prior art asserted, and statutory bases (§ 102 / § 103 / § 112) for this petition are not detailed in the provided data.
• Institution decision: Denied (Discretionary Denial). The PTAB declined to institute the IPR. Since October 2025, Director John Squires has personally controlled all institution determinations, often issuing summary orders without reasoning or analysis for denials. Discretionary denials can be based on factors such as parallel district court litigation, "settled expectations" based on patent age, or petitioner delay, among others.
• Final Written Decision (if issued): Not issued, as institution was denied.
• Settlement / termination: No settlement or termination explicitly stated; the proceeding concluded with a discretionary denial of institution.
• Appeal: No Federal Circuit appeal related to a Final Written Decision, as no such decision was rendered.
• Defensive value: This IPR did not result in any claims being invalidated, nor did it substantively test the patentability of the claims on the merits. A defendant still faces a patent whose claims have not been judicially reviewed by the PTAB for patentability over the cited prior art. The discretionary denial means the underlying patentability arguments were not fully explored.

Strategic summary

Currently, none of the claims of US Patent 9055868 have been canceled or sustained through a final written decision from the provided PTAB proceeding. The single identified IPR (IPR2025-01249) was discretionarily denied institution, meaning the PTAB did not reach the merits of the patentability challenge. Therefore, all claims of US9055868 can be considered UNTESTED in the context of AIA trial proceedings to date.

Regarding the estoppel landscape, since IPR2025-01249 was denied institution on discretionary grounds rather than on the merits of patentability, it is unlikely to trigger the full estoppel provisions of 35 U.S.C. § 315(e)(2) for the petitioner. This means that, theoretically, the same petitioner (and their privies) might not be barred from raising the same grounds in a future proceeding if discretionary factors change, although the PTAB has discretion to consider prior denials. For a different defendant currently being asserted against, all prior-art grounds would generally still be available for a new IPR petition, as the merits were not decided in IPR2025-01249.

The signal from this single proceeding is limited. The discretionary denial indicates a procedural hurdle rather than a substantive victory or loss on patentability. The petitioner was "SAMSUNG ELECTRONICS CO., LTD. et al.", suggesting a large entity sought to challenge the patent. The Google Patents record indicates "Unified Patents PTAB Data" as a petitioner for IPR2025-01249, which might imply involvement by a defensive aggregator. The current PTAB environment, particularly since October 2025 under Director John Squires, has seen a significant increase in discretionary denials, often without detailed reasoning, indicating a more restrictive approach to IPR institution.

Recommended next steps

• Since IPR2025-01249 resulted in a discretionary denial of institution and not a Final Written Decision on the merits, there are no claims invalidated or sustained by this proceeding to explicitly link to. The procedural status means the patent claims have not been substantively challenged and affirmed or rejected by the PTAB.
• No active proceedings are currently pending that would require monitoring for trial-stage milestones.
• Given that there has been only one IPR filing which was discretionarily denied, and the patent is involved in multiple district court litigations (as indicated by the Google Patents record), a defendant should carefully consider the grounds for the discretionary denial of IPR2025-01249. If the patent is being asserted, the absence of successful PTAB challenges means that any new IPR petition would be a fresh attempt at invalidation, and the arguments presented in the denied petition should be reviewed to understand potential PTAB concerns or strategies to avoid.